Your browser doesn't support javascript.
loading
Bone marrow stromal cell-mediated degradation of CD20 leads to primary rituximab resistance in mantle cell lymphoma.
Kuroda, Yoshiaki; Yashima-Abo, Akiko; Koyama, Daisuke; Kikuchi, Jiro; Mori, Shigehisa; Ito, Shigeki; Furukawa, Yusuke.
Afiliação
  • Kuroda Y; Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
  • Yashima-Abo A; Department of Hematology, National Hospital Organization Hiroshimanishi Medical Center, 4-1-1 Kuba, Otake, Hiroshima, 739-0696, Japan.
  • Koyama D; Department of Pathology, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa, Iwate, 028-3694, Japan.
  • Kikuchi J; Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
  • Mori S; Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
  • Ito S; Medical Education Center, Saitama Medical University, 38 Morohongo, Saitama, 350-0495, Japan.
  • Furukawa Y; Hematology and Oncology, Department of Internal Medicine, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa, Iwate, 028-3694, Japan.
Leukemia ; 35(5): 1506-1510, 2021 05.
Article em En | MEDLINE | ID: mdl-32929128
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Células Estromais / Resistencia a Medicamentos Antineoplásicos / Antígenos CD20 / Linfoma de Célula do Manto / Rituximab / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Células Estromais / Resistencia a Medicamentos Antineoplásicos / Antígenos CD20 / Linfoma de Célula do Manto / Rituximab / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article